Targeted Agent Shows Promise In Biliary Cancer Study
Friday, April 24, 2009 - 00:08
in Health & Medicine
An experimental agent has shown promising results in people with advanced biliary cancer, according new research. The agent, known as AZD6244, blocks enzymes cancer cells need to proliferate and survive.